Clinical Guides
Nausea and Vomiting of Pregnancy: Stepwise Care and Hyperemesis Safety
An India-contextualised educational guide to distinguishing nausea and vomiting of pregnancy from dangerous alternatives and delivering clinically focused, stepwise hyperemesis care.
MedNext Academy | 14 min read
Nausea and Vomiting of Pregnancy: Stepwise Care and Hyperemesis Safety
An India-contextualised educational guide to distinguishing nausea and vomiting of pregnancy from dangerous alternatives and delivering clinically focused, stepwise hyperemesis care.
Summary
Nausea and vomiting of pregnancy (NVP) commonly begins early in gestation; RCOG’s 2024 patient information states that it usually starts between weeks 4 and 7 and settles by 20 weeks in 9 of 10 affected people. Hyperemesis gravidarum (HG) is the severe end of the spectrum, with inability to eat or drink normally and functional impairment; it may cause dehydration, weight loss, electrolyte disturbance, nutritional deficiency, thrombosis risk and psychological harm. Do not minimise symptoms as ‘morning sickness’: symptoms occur at any time and severity is determined by intake, hydration, function, observations, weight trajectory, comorbidity and investigation, not by a single vomiting count or ketonuria.
The clinical sequence is: rule out instability and alternative diagnoses; quantify severity with a consistent validated tool such as PUQE or HELP; choose community, ambulatory, emergency or inpatient care based on safety; use antiemetics from different classes when one agent fails; restore fluid and electrolytes; give thiamine before dextrose or parenteral nutrition; and reassess repeatedly. RCOG states that ketonuria is not an indicator of dehydration and should not be used to assess severity. It also recommends daily urea and serum electrolytes for people requiring intravenous fluids.
This guide quotes RCOG’s exact 2024 UK antiemetic regimens solely as a transparent evidence reference. It is not an Indian drug chart. In India, every product, dose, route, duration, contraindication, interaction, monitoring and low-molecular-weight-heparin regimen must be confirmed against current CDSCO authorisation, hospital formulary and obstetric protocol before prescribing.
How Common Is It?
NVP is common, but common does not mean harmless. RCOG’s 2024 patient information says that NVP affects most pregnant women and that HG may affect up to 3 in 100 pregnant women and people. Those figures are from a UK professional source and should not be repackaged as an Indian prevalence estimate. Service burden is often underestimated because patients may manage at home, seek repeated brief care, lose work or study time, or present only when dehydration is advanced.
Clinical classification should focus on what the illness is doing. A person who can drink, take medicines and perform usual activities with mild symptoms may be managed in the community with planned review. A person who cannot retain fluids or essential medicines, has substantial weight loss, reduced urine output, orthostatic symptoms, electrolyte or renal abnormalities, diabetes, ketosis or a diagnostic concern needs more urgent assessment. HG can coexist with multiple gestation or trophoblastic disease, but neither is required for diagnosis.
Do not make ketonuria the entry ticket to care. RCOG explicitly says it is not a reliable indicator of dehydration or disease severity. A validated tool may make deterioration visible across visits, but no score substitutes for clinical judgement. In the Indian setting, travel time, cost, food insecurity, inability to return, a lack of laboratory monitoring or a missing ambulatory service can turn moderate biochemical risk into a reason for earlier referral. NHM’s 2026 SUMAN Roadmap lists severe nausea or vomiting, inability to drink, no urine for over 8 hours and severe dehydration among pregnancy danger signs.
Risk Factors
Previous NVP or HG is important in planning because recurrence is possible and early treatment can prevent repeated dehydration. RCOG discusses associations with multiple pregnancy and gestational trophoblastic disease, but these associations do not establish the diagnosis. Ask about previous severity, medicines that worked or caused adverse reactions, admission history, thrombosis history, diabetes, renal disease, thyroid disease, gastrointestinal disease, bariatric surgery, epilepsy, psychiatric medicines and HIV treatment. Persistent vomiting can prevent absorption of essential oral medicines, so it is unsafe to prescribe antiemetics in isolation from the rest of the medication list.
Risk accumulates through physiology and access. Pregnancy, dehydration, immobility, hospital admission and personal or family VTE factors require a documented thrombosis assessment. RCOG’s NVP guideline says people admitted with HG should be offered low-molecular-weight-heparin thromboprophylaxis and people managed in the community should be assessed for VTE risk. The cited recommendation does not authorise a universal dose; bleeding risk, renal function, weight, gestation, timing of birth and the local protocol determine any regimen.
Nutritional risk rises with prolonged vomiting or very low intake. Thiamine deficiency can lead to Wernicke encephalopathy, sometimes without the full textbook triad. Consider also potassium, sodium, glucose, acid-base and renal abnormalities. Diabetes deserves same-day metabolic assessment because vomiting and reduced intake can accompany diabetic ketoacidosis or starvation ketosis. Psychological risk is not an alternative explanation for severe illness: NVP and HG can worsen mood, relationships, work, housing and safety. Ask sensitively about distress, self-harm thoughts, food access, coercion and support without blaming the patient for symptoms.
Diagnosis
History
Confirm gestation and symptom onset. Record nausea, vomiting and retching over the preceding 24 hours, fluid and food tolerance, urine output, weight change, function, sleep, triggers, prescribed and over-the-counter medicines, and response or adverse effects from prior antiemetics. Ask about abdominal or pelvic pain, fever, diarrhoea, urinary symptoms, headache, visual symptoms, neurological change, haematemesis, jaundice, chest symptoms, calf symptoms, substance use and sick contacts. Establish diabetes, endocrine, renal, gastrointestinal and psychiatric history, previous HG, multiple-pregnancy risk, and safety barriers to return.
Examination
Assess airway, consciousness, temperature, pulse, blood pressure including postural symptoms when appropriate, respiratory rate, oxygen saturation, weight and hydration. Look for dry mucosa, poor perfusion, reduced urine, abdominal tenderness or guarding, jaundice, goitre, neurological abnormalities and signs of VTE. Obstetric examination and fetal assessment should be appropriate to gestation and symptoms. Do not normalise focal abdominal tenderness, peritonism, fever, hypertension, confusion or abnormal breathing as pregnancy sickness.
Investigations
Use PUQE or HELP consistently if available. RCOG recommends that ketonuria not be used to measure severity. Urinalysis may nevertheless assist a broader assessment of infection or glycosuria. For intravenous treatment, admission, severe disease or relevant comorbidity, check urea, electrolytes and renal function; RCOG specifies daily urea and serum electrolytes while intravenous fluids are required. Add glucose, blood ketones, blood gas, full blood count, liver tests, lipase, thyroid tests, urine culture and ultrasound selectively according to the presentation. Ultrasound is appropriate when viability, dating, multiple gestation or trophoblastic disease is uncertain, not as a substitute for treating dehydration. Interpret mild liver or thyroid abnormalities in clinical context and seek senior advice for major abnormalities, acidosis or atypical onset.
Differential Diagnosis
NVP usually begins before 16 weeks. New onset after 16 weeks, abrupt worsening, focal pain, fever, jaundice, marked hypertension, neurological signs or an abnormal respiratory pattern requires a deliberate alternative-diagnosis search. Gastrointestinal causes include gastroenteritis, hepatitis, pancreatitis, biliary disease, appendicitis, bowel obstruction, peptic disease and medication toxicity. Urinary infection, pyelonephritis and renal colic may present with vomiting. Consider migraine, vestibular disease, raised intracranial pressure and other neurological causes when headache or neurological findings are prominent.
Metabolic disease can be fatal if missed. In diabetes, test glucose, ketones and acid-base status promptly when symptomatic. Starvation ketosis and diabetic ketoacidosis are not routine HG. Hyperthyroidism may accompany severe early pregnancy symptoms, but abnormal thyroid tests should not automatically be labelled primary thyroid disease or treated without clinical assessment. Adrenal, renal, hepatic and calcium disorders require their own pathways. Cannabis use can be relevant, but taking a non-judgemental history is safer than assuming causation.
Obstetric alternatives include multiple gestation and trophoblastic disease early in pregnancy, and later-pregnancy disorders when gestation and features fit. Vaginal bleeding, fluid loss, severe headache, visual symptoms or reduced fetal movement require the appropriate obstetric emergency pathway. Haematemesis may follow repeated retching but must still be assessed for severity and cause; RCOG states that oesophago-gastroduodenoscopy is safe in pregnancy when haematemesis or severe epigastric pain indicates it. The diagnostic error to avoid is anchoring on pregnancy and repeatedly changing antiemetics while the patient has surgical, infective, metabolic or neurological disease.
Management
Match the setting to clinical safety. Community care is reasonable only when intake, observations, function, comorbidity, home support and return access are adequate. Use tolerable fluids and foods, trigger avoidance where useful, psychosocial support, a documented antiemetic plan and prompt review. Ambulatory day care can provide intravenous fluids, antiemetics, thiamine and reassessment when the person is stable and the service can verify response before discharge. Admit or urgently refer for significant dehydration, inability to retain oral fluid or essential medication, electrolyte or renal disturbance, metabolic concern, rapid weight loss, failed ambulatory care, serious comorbidity, diagnostic uncertainty or an unsafe social situation.
RCOG advises combinations of drugs from different classes when a single antiemetic is inadequate, and non-oral routes may be needed when vomiting prevents absorption. Its first-line UK options are H1-antihistamines, phenothiazines and doxylamine/pyridoxine; metoclopramide and ondansetron are second-line options, with corticosteroids reserved for refractory disease after standard therapies fail. The exact source regimen is reproduced in Prescribing Information and must be locally authorised before use in India. Ask about previous adverse drug reactions and stop a medicine promptly if an adverse reaction occurs.
For intravenous rehydration, RCOG recommends normal saline 0.9% with potassium chloride in each bag, guided by daily electrolyte monitoring. Do not administer unmonitored potassium in a setting without reliable electrolytes and renal assessment; refer instead. RCOG does not recommend dextrose infusions for replacement in NVP/HG because they can precipitate Wernicke encephalopathy in thiamine deficiency. Give thiamine before dextrose or parenteral nutrition. Monitor fluid balance, urine output, weight, symptoms, electrolyte response, mental state and ability to retain oral medication. Add acid suppression only when reflux, oesophagitis or gastritis develops, using the local formulary.
Prescribing Information
The following is the RCOG Green-top Guideline No. 69 Appendix III UK schedule, quoted verbatim in substance for source traceability, not adopted as an Indian protocol. First line: doxylamine/pyridoxine 20/20 mg orally at night, increasing by 10/10 mg in the morning and 10/10 mg at lunchtime if required; cyclizine 50 mg orally, intramuscularly or intravenously every 8 hours; prochlorperazine 5–10 mg orally every 6–8 hours or 3 mg buccally, 12.5 mg intramuscularly/intravenously every 8 hours, or 25 mg rectally daily; promethazine 12.5–25 mg orally, intramuscularly or intravenously every 4–8 hours; chlorpromazine 10–25 mg orally, intramuscularly or intravenously every 4–6 hours.
Second line: metoclopramide 5–10 mg orally, intravenously, intramuscularly or subcutaneously every 8 hours; domperidone 10 mg orally every 8 hours or 30 mg rectally every 12 hours; ondansetron 4 mg orally every 8 hours or 8 mg orally every 12 hours, 8 mg intravenously over 15 minutes every 12 hours, or 16 mg rectally daily. RCOG places metoclopramide second line because of extrapyramidal effects and says intravenous doses should be given by slow bolus over at least 3 minutes to reduce that risk. Ondansetron is second line after ineffective first-line therapy; RCOG describes a very small absolute first-trimester orofacial-cleft increase that must be balanced against poorly managed HG. Constipation may require laxatives.
Third line: hydrocortisone 100 mg intravenously twice daily, then after improvement prednisolone 40–50 mg orally daily, tapered by 5–10 mg weekly to the lowest controlling dose. RCOG reserves corticosteroids for standard-treatment failure and asks for blood-pressure monitoring and diabetes screening. Give oral thiamine 100 mg three times daily, or intravenous thiamine as vitamin B complex, to all admitted with vomiting or severely reduced intake, especially before dextrose or parenteral nutrition. These doses, routes, intervals, duration and monitoring claims apply to the cited UK guideline only; confirm every element against current Indian product labelling, hospital policy and specialist advice before prescribing.
When to Refer
Arrange emergency assessment or admission for haemodynamic instability, syncope, severe dehydration, no meaningful urine output, abnormal electrolytes, acute kidney injury, acidosis, diabetes with ketosis or hyperglycaemia, altered mental state, ataxia, eye-movement change, seizure, severe headache, fever, jaundice, haematemesis, focal or severe abdominal pain, suspected VTE or inability to retain any fluid. NHM’s current SUMAN Roadmap identifies severe vomiting, inability to drink, dark urine or no urine for over 8 hours, severe dehydration, fainting and confusion as danger signs. These need a service able to assess and stabilise pregnant patients, not reassurance by telephone alone.
Refer to obstetrics or a capable ambulatory unit if oral management fails, symptoms are functionally severe, weight falls, medications cannot be absorbed, multiple gestation or trophoblastic disease is possible, or regular review cannot be safely delivered. Seek diabetes, medical, gastroenterology, endocrinology, dietetic, pharmacy, mental-health or safeguarding input according to comorbidity and findings. Refractory HG may need multidisciplinary nutrition support; RCOG places enteral or parenteral feeding after medical therapies and correction of electrolyte or metabolic disturbance have been considered.
Refer or discuss before using a drug or route that is unavailable, unlicensed or unfamiliar locally. Transfer early rather than giving potassium without laboratory monitoring, dextrose without thiamine, an unverified antiemetic regimen or a guessed LMWH dose. A handover should include gestation, symptom score and duration, weight trajectory, oral intake and urine output, observations, differential considered, glucose/ketones/acid-base data when indicated, laboratory results, fluids, antiemetics and routes already used, thiamine timing, VTE assessment, comorbidities, social barriers and the reason for escalation.
Red Flags
Wernicke encephalopathy is a preventable neurological emergency in prolonged vomiting. Confusion, unsteadiness, abnormal eye movements, reduced consciousness or memory change requires immediate senior treatment; do not wait for the complete classic triad. RCOG explains that dextrose-containing solutions can precipitate Wernicke encephalopathy in thiamine-deficient states. That is why thiamine is given before dextrose or parenteral nutrition.
Deep or rapid breathing, abdominal pain, drowsiness, abnormal glucose or raised ketones may signal ketoacidosis. Oliguria, tachycardia, hypotension, severe weakness, acute kidney injury, marked electrolyte derangement or inability to drink signals major dehydration. Fever, peritonism, persistent focal pain, jaundice, severe epigastric pain, haematemesis, neurological deficit, chest pain, breathlessness, unilateral leg swelling and haemoptysis require alternative or additional pathways. A patient who returns repeatedly despite antiemetics needs a diagnosis, route, adherence, nutrition, medication-access and social-safety review—not a label of ‘frequent attender’.
Pregnancy-specific danger signs retain their urgency: bleeding, leaking fluid, severe headache or visual symptoms, seizures, and reduced fetal movements at the relevant gestation. NHM’s SUMAN Roadmap also flags confusion, fainting, severe anxiety, no urine, severe dehydration, severe vomiting and inability to drink. At discharge, give a written action plan that states when to return, where to go after hours, how to take the confirmed antiemetic schedule and why thiamine/dextrose sequencing matters. reviewed educational content cannot substitute for those real emergency arrangements.
Indian Clinical Context
No current India-wide hyperemesis-specific drug schedule was identified for this draft. It would be unsafe to present RCOG’s UK table as an Indian standard of care. The RCOG regimen is retained with explicit jurisdiction labels because it is a current, detailed professional guideline; use it only as a discussion framework until an Indian obstetric service verifies current CDSCO registration, local formulary availability, dose, route, monitoring and referral capacity. This applies especially to doxylamine/pyridoxine products, rectal formulations, intravenous antiemetics, corticosteroids, thiamine preparations, potassium chloride and LMWH.
NHM’s 2026 SUMAN Roadmap gives practical national danger-sign language: severe nausea or vomiting, inability to drink, no urine for more than 8 hours, dark urine, severe dehydration, weakness, dizziness, fainting and confusion need escalation. In a primary, rural or travel-limited setting, absent electrolyte testing is not permission to administer unmonitored potassium or make a remote HG diagnosis. It is a lower threshold for referral to an emergency obstetric-capable facility. Start stabilisation within competence, communicate early and do not delay transfer for administrative registration or a perfect diagnostic label.
Offer culturally and economically feasible advice: small tolerated portions and fluids rather than a rigid menu, written plans in the patient’s preferred language, family involvement only with consent, and arrangements that account for transport, wages, caregiving and pharmacy access. Screen for food insecurity and coercion. Indian care must preserve autonomy: symptom severity is not a moral failing and neither family preference nor cost justifies withholding indicated assessment. This draft is awaiting independent review by the MedNext Clinical Team and must not be used as a substitute for a local protocol.
NMC Competency Mapping
A learner should recognise NVP and HG as a continuum, quantify functional impact, identify dehydration and red flags, and distinguish pregnancy sickness from surgical, infective, metabolic, neurological and obstetric alternatives. Under supervision, they should take a focused history; measure observations and weight; assess hydration, neurological status and abdominal signs; interpret electrolytes, renal function, glucose, ketones and acid-base data in context; and explain why ketonuria alone does not grade HG. They should know when ultrasound, urine testing and specialist investigation are indicated without ordering tests indiscriminately.
Safe therapeutics means more than recalling a drug name. The learner should understand class-based antiemetic escalation, route change when absorption fails, the extrapyramidal risk of metoclopramide, the counselling context for ondansetron, daily electrolytes during intravenous fluid therapy, thiamine before dextrose, and VTE risk assessment. They must not independently prescribe potassium, parenteral nutrition, corticosteroids or LMWH without a current local protocol and authorised supervision. The NMC curriculum’s requirement to prescribe safely and appropriately in pregnancy and lactation supports this approach; it is not itself a source for antiemetic doses.
Assessment can include an OSCE with early-pregnancy vomiting plus diabetes, a fluid/electrolyte chart, identification of Wernicke warning signs, a structured referral handover and counselling that validates symptoms while explaining medicine risk-benefit. Exact competency codes should be mapped from the institution’s current NMC ledger. Learners should document jurisdiction limits and never pass a foreign guideline’s dose table off as a local Indian order set.
Key Exam Pearls for NEET PG
NVP usually starts in early pregnancy, commonly weeks 4–7, and settles by 20 weeks in most affected people. HG is severe NVP with impaired intake and function; assess dehydration, weight, observations, comorbidity and blood results. PUQE and HELP can support serial assessment. Ketonuria does not measure severity or dehydration. Onset after 16 weeks, focal pain, fever, jaundice, severe headache, abnormal breathing or neurological findings should widen the differential.
For severe disease, assess electrolytes, renal function and glucose; check acid-base status and ketones when ketoacidosis is possible. RCOG recommends normal saline 0.9% with potassium chloride in each bag, with daily electrolyte monitoring, and daily urea/electrolytes while intravenous fluids are required. Give thiamine before dextrose or parenteral nutrition to reduce Wernicke risk. People admitted with HG should be offered LMWH thromboprophylaxis after risk and contraindication assessment; the dose is protocol-specific.
RCOG first-line UK antiemetics include doxylamine/pyridoxine, cyclizine, prochlorperazine, promethazine and chlorpromazine. Metoclopramide and ondansetron are second line; steroids are refractory third line. Combination drugs from different classes and non-oral routes may be required. Metoclopramide has extrapyramidal risk, and ondansetron needs first-trimester risk-benefit counselling. In India, memorise the reasoning but prescribe only from the current local formulary and obstetric protocol.
Frequently Asked Questions
Is ketonuria required before hyperemesis gravidarum can be treated?
No. RCOG states that ketonuria is not an indicator of dehydration and should not be used to assess severity. Treat the person in front of you: intake, urine output, weight, vital signs, functional loss, examination, comorbidity and relevant blood tests determine urgency. Ketones may be important when ketoacidosis is suspected, but they do not decide whether a person with severe vomiting deserves hydration, antiemetics or referral.
Why must thiamine be given before dextrose in prolonged vomiting?
Prolonged vomiting or very low intake can deplete thiamine. RCOG warns that dextrose-containing solutions can precipitate Wernicke encephalopathy in thiamine-deficient states and recommends thiamine before dextrose or parenteral nutrition. Confusion, unsteady gait, eye-movement abnormalities, memory change or reduced consciousness needs emergency assessment; waiting for the full classic triad is unsafe.
Are antiemetic doses in this guide automatically suitable in India?
No. The detailed regimens are RCOG 2024 UK guidance, included with exact source labelling. They are not a CDSCO-approved Indian order set. A local clinician must confirm registration, formulation, route, dose, duration, contraindications, interactions, monitoring and availability in the current hospital formulary. This is particularly important for injectable or rectal routes, corticosteroids, potassium chloride and thromboprophylaxis.
When does pregnancy vomiting need hospital or emergency assessment?
Seek urgent assessment when fluids cannot be kept down, urine output is markedly reduced, fainting, confusion, severe weakness, blood in vomit, fever, severe or focal abdominal pain, jaundice, abnormal breathing, chest symptoms, leg swelling, diabetes with ketones or inability to retain essential medicines occurs. NHM also lists severe vomiting, inability to drink, no urine for more than 8 hours and severe dehydration as pregnancy danger signs.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic